RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
SLVCX
Price
$15.52
Change
+$0.10 (+0.65%)
Updated
Jul 31 closing price
Net Assets
14.69M
Interact to see
Advertisement

RMEBX vs SLVCX

RMEBX vs SLVCX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. SLVCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SLVCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. SLVCX (14.7M). RMEBX pays higher dividends than SLVCX: RMEBX (0.99) vs SLVCX (0.00). RMEBX was incepted earlier than SLVCX: RMEBX (12 years) vs SLVCX (28 years). SLVCX (2.77) is less costly to investors than RMEBX (1.07). SLVCX is a more actively managed with annual turnover of: 93.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than SLVCX: RMEBX (250) vs SLVCX (2500). RMEBX annual gain was more profitable for investors over the last year : 8.96 vs. SLVCX (-15.74). RMEBX return over 5 years is better than : 36.13 vs. SLVCX (-37.01).
RMEBXSLVCXRMEBX / SLVCX
Total Expense Ratio1.072.7739%
Annual Report Gross Expense Ratio1.072.7739%
Fund Existence12 years28 years-
Gain YTD9.4160.9101,034%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets118B14.7M802,721%
Annual Yield % from dividends0.990.00-
Returns for 1 year8.96-15.74-57%
Returns for 3 years32.63-15.88-205%
Returns for 5 years36.13-37.01-98%
Returns for 10 years90.64-11.52-787%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A